Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour?

British Journal of Neurosurgery

Volumn 18, Issue 5, 2004, Pages 500-505

  Plowman, P N ^a   Besser, G M ^a   Shipley, J ^b   Summersgill, B ^b   Geddes, J ^c   Afshar, F ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; ETOPOSIDE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHROMOSOME ABERRATIONS; CISPLATIN; CRANIOPHARYNGIOMA; ETOPOSIDE; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS;

EID: 11344266083     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690400012400     Document Type: Article

References (41)

1. Cushing H. The craniopharyngiomas, in: Intracranial tumors. Notes upon a series of two thousand verified cases with surgical mortality percentage. Illinois: Thomas Springfield, 1932:93-8.
2. Heidemann RL, Packer RJ, Albright LA, Freeman CR, Rorke LB. Tumors of the central nervous system, in: Pizzo PA, Poplak DG (eds) Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven, 1997:633-97.
3. Salyer D, Carter D. Squamous carcinoma arising in the pituitary gland. Cancer 1973;31:713-8.
4. Nelson GA, Bastian FO, Schlitt M, White RL. Malignant transformation in craniopharyngioma. Neurosurgery 1988;22:427-9.
5. Kristopaitis T, Thomas C, Petruzella GJ, Lee JM. Malignant craniopharyngioma. Arch Pathol Lab Med 2000;124:1356-60.
6. Harris PE, Perry L, Chard T, et al. Immunoreactive human chorionic gonadotrophin from the cyst fluid and CSF of patients with craniopharyngioma. Clin Endocrinol 1988;29:503-8.
7. Janmohamed S, Grossman AB, Metcalfe K, et al. Suprasellar germ cell tumours - specific problems and the evolution of optimal management with a combined chem.-radiotherapy regimen. Clin Endocrinol 2002;57:487-500.
8. Summersgill B, Goker H, Osin P, et al. Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples. Diagn Mol Pathol 1998;7:260-6.
9. Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 1998;77:305-13.
10. Cohnheim J. Vorlesungen uber algemeine Pathologie, erster Band. Berlin: Hirschwald, 1882.
11. Freidman NB, Moore AB. Tumors of the testis-a report on 922 cases. Mil Surgeon 1946;99:573-93.
12. Dixon FJ, Moore RA. Testicular tumours-a clinicopathological study. Cancer 1953;6:427-54.
13. Teilum G. Classification of endodermal sinus tumor (mewsoblastoma vitellinum) and so-called embryonal carcinoma of the ovary. Acta Pathol Microbiol Scand 1965;64:407-29.
14. Sano K. So called intracranial germ cell tumours: are they really of germ cell origin? Br J Neurosurg 1995;9:391-401.
15. Sano K. Intracranial dysembryogenetic tumours: pathogenesis and their order of malignancy. Neurosurg Rev 2001;24:162-7.
16. Netsky MG. Epidermoid tumors. Review of the literature. Surg Neurol 1998;29:477-83.
17. Stevens LC. Experimental production of testicular teratomas in mice. Proc Natl Acad Sci USA 1964;52:654-61.
18. Atkin NB, Baker MC. I(12p): specific chromosome marker in seminoma and teratoma of testis? Cancer Genet Cytogenet 1983;10:199-204.
19. Chaganti RS, Rodriguez E, Mathew S. Origin of adult male mediastinal germ-cell tumours. Lancet 1994;343:1130-2.
20. Motzer RJ, Rodriguez E, Reuter VE, et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 1995;13:274-82.
21. Stock C, Strehl S, Fink FM, et al. Isochromosome 12p and maternal loss of lp36 in pediatric testicular germ cell tumor. Cancer Genet Cytogenet 1996;91:95-100.
22. Bussey KJ, Lawce HJ, Olson SB, et al. Chromosome abnormalities of eighty one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences-a Children's Cancer Group Study. Genes, Chromos Cancer 1999;25:134-46.
23. Silver SA, Wiley JM, Perlman EJ. DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol 1994;7:951-6.
24. Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chroms Cancer 2002;34:115-25.
25. Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr 2001;213:204-11.
26. Yu IT, Griffin CA, Phillips PC, Strauss LC, Perlman EJ. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridisation. Lab Invest 1995;72:419-23.
27. Okada Y, Nishikawa R, Matsutari M, Louis DN. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exper Neurol 2002;61:531-81.
28. Lemos R, Barbieri-Neto J, Casartelli C. Primary intracranial germ cell tumours without an isochrome 12p. Cancer Genet Cytogenet 1998;100:124-8.
29. Rickert CH, Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngioma. J Neurol Neurosurg Psychiatry 2003;74:260-1.
30. Rienstein S, Adams EF, Pilzer D, et al. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 2003;98:162-4.
31. Gorski GK, McMorrow LE, Donaldson MH, Freed M. Multiple chromosomal abnormalities in a case of craniopharyngioma. Cancer Genet Cytogenet 1992;60:212-13.
32. Karnes PS, Tran TN, Cui MY, et al. Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 1992;59:12-19.
33. Riou G, Barrios M, Prost S, et al. The p53 and mdm-2 genes in human testicular germ cell tumors. Mol Carcinogenesis 1995;12:124-31.
34. Mueller T, Voigt W, Simon H, et al. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003;63:513-21.
35. Nada R, Mohan H, Dhir KK, Kak VK. Suprasellar malignant mixed germ cell tumour presenting as craniopharyngioma. Neurol India 2000;48:381-4.
36. Mottolese C, Stan H, Hermier M, et al. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Child Nerv Syst 2001;17:724-30.
37. Park DH, Park JY, Kim JH, et al. Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Kor Med Sci 2002;17:254-9.
38. Takahashi H, Nakazawa S, Shimira T. Evaluation of intracranial injection of bleomycin for craniopharyngioma of childhood. J Neurosurg 1985;62:120-8.
39. Bremer Am, Nguyen TQ, Balsyo R. Therapeutic benefits of combination chemotherapy with vincristine, BCNU and procarbazine on recurrent cystic craniopharyngioma. J Neuroncol 1994;2:47-50.
40. Lippens RJ, Rotteveel JJ, Otten BJ, Merx H. Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Eur J Paed Neurol 1998;2:263-8.
41. Plowman PN, Kingston JE, Sebag-Montefiore DS, Doughty D. Clinical efficacy of perceived 'CNS friendly' chemoradiotherapy for primary intracranial germ cell tumour. Clin Oncol 1997;9:48-53.